X-Ray crystallography
Experimental
Single crystals of compounds 1–4 were harvested directly from
the slow evaporation preparations and in all cases suitable
single crystals (i.e. those found by inspection to have
well-defined morphology and that extinguished plane
polarised light uniformly) were attached to the end of a
MiTeGen mount using paratone oil. Intensity data were
collected on a Bruker SMART Apex CCD single-crystal
X-ray diffractometer14 equipped with an Oxford Cryosystems
Cryostream Plus cooling system set at 100 K. The system
was operated at 1.2 kW power (40 kV, 30 mA) using mono-
chromated Mo-Ka radiation (l = 0.71073 A). Data reduction
was carried out by means of a standard procedure using
the Bruker SAINT software package.15 Where necessary,
empirical corrections were performed using SADABS.16,17
All crystal structures were solved and refined using SHELX-97.18
X-Seed19 was used as a graphical interface for SHELX.
Structures were solved either by direct methods or a combination
of Patterson methods and partial structure expansion using
SHELXS-97. Structures were expanded by iterative examina-
tion of difference Fourier maps following least squares
refinements of earlier models. All non-hydrogen atoms were
refined anisotropically by means of full-matrix least squares
calculations on F2 using SHELXL-97. Where appropriate,
hydrogen atoms were placed in calculated positions using
riding models and assigned isotropic thermal parameters
1.2–1.5 times Ueq of their parent atoms. Hydroxyl and water
hydrogen atoms were located in difference electron density
maps and refined independently.
All reagents and solvents were purchased and used as received.
IR spectra were recorded on a Nexus 670 FT-IR instrument
(Thermo Nicolet Instruments, USA) in the spectral range
4000–400 cmꢁ1 using the KBr pellet method. LC ESI-MS
analysis was carried out on a Waters API Quattro Micro mass
spectrometer with an electrospray ionisation source and
1H-NMR and 13C-NMR spectra were recorded on a Varian
Unity INOVA (400 MHz).
Synthesis of 1,3-bis(1-imidazolyl-2-thione)-2,4,6-trimethyl-
benzene (L)
2-Mercaptoimidazole (2.01 g, 20 mmol) was added to 2,4-
bis(chloromethyl)-1,3,5-trimethylbenzene (1.09 g, 5.0 mmol) in
200 mL of MeOH. The resulting solution was refluxed for 24 h.
The solvent was then removed under reduced pressure and
yielded a yellow oil, to which K2CO3 (6.91 g, 50 mmol) in
100 mL of H2O was added. The solution was stirred until the
product precipitated. The white solid was then filtered, washed
with 100 mL H2O and left to air dry. Yield: 92.5%. Mp:
168–170 1C; IR (KBr pellet): nmax 3434 (N-H of Im), 2363,
1858, 1605 (aromatic CQC), 1547, 1414 (CH2 bend), 1232
(CH2–S wag), 1096, 963, 746 cmꢁ1 1H-NMR (DMSO-D6,
;
400 MHz): d 2.18 (3H, s, ArCH3), 4.14 (4H, s, CH2S), 6.91
(2H, s, ArHa), 6.94 (1H, s, ArHb), 7.05 (4H, s, CN(H)CHCHN);
13C-NMR (DMSO-D6, 75.5 MHz): d 20.69, 37.6, 123.7, 126.1,
137.5, 137.7, 138.3; MS (ESI+): m/z 317 (100%, [(M + H]+)],
218 (20%, M+ ꢁ SIm), 159 (87%).
Preparation of complexes 1–4
Crystal data for 1. C17H22CdI2N4OS2, M = 728.71, colourless
plate, 0.11 ꢂ 0.09 ꢂ 0.06 mm, monoclinic, space group P21/c
(No. 14), a = 13.470(3), b = 11.610(3), c = 15.371(3) A,
Synthesis of {[CdLI2]ꢀH2O}n (1). 10.1 mg L (0.029 mmol)
was dissolved in 3 mL of MeOH and added to 10.6 mg
(0.029 mmol) CdI2 dissolved in 2 mL MeOH. The solvent
was allowed to evaporate slowly and after a period of 3 weeks
colourless crystals formed, and the structure was elucidated by
single-crystal X-ray diffraction.
b = 99.904(4)1, V = 2367.9(9) A3, Z = 4, Dc = 2.044 g cmꢁ3
,
F000 = 1384, Mo-Ka radiation, l = 0.71073 A, T = 100(2) K,
2ymax = 56.51, 14 624 reflections collected, 5506 unique
(Rint = 0.0349). Final GooF = 1.076, R1 = 0.0378, wR2 =
0.0827, R indices based on 4801 reflections with I > 2s(I)
(refinement on F2), 255 parameters, 3 restraints. Lp and
Synthesis of {[CdLI2]ꢀCH3OH}n (2). 20.2 mg L (0.058 mmol)
was dissolved in 3 mL of MeOH and added to 10.6 mg
(0.029 mmol) CdI2 dissolved in 2 mL MeOH. The solvent
was allowed to evaporate slowly and after a period of one
month colourless crystals formed, and the structure was
elucidated by single-crystal X-ray diffraction.
absorption corrections applied, m = 3.720 mmꢁ1
.
Crystal data for 2. C18H24CdI2N4OS2, M = 742.73, 0.24 ꢂ
0.17 ꢂ 0.11 mm, monoclinic, space group C2/c (No. 15), a =
31.625(3), b = 11.0517(10), c = 16.3433(15) A, b =
119.0840(10)1, V = 4992.0(8) A3, Z = 8, Dc = 1.977 g cmꢁ3
,
F
000 = 2832, Mo-Ka radiation, l = 0.71073 A, T = 100(2) K,
Synthesis of {[CdLI2]ꢀ2CH3CN}n (3). 10.1 mg L (0.029 mmol)
was dissolved in 3 mL of MeCN and added to 10.6 mg
(0.029 mmol) CdI2 dissolved in 2 mL MeCN. The solvent
was allowed to evaporate slowly and after a period of 2 weeks
colourless crystals formed, and the structure was elucidated by
single-crystal X-ray diffraction.
2ymax = 56.61, 15 354 reflections collected, 5813 unique
(Rint = 0.0339). Final GooF = 1.060, R1 = 0.0396, wR2 =
0.0885, R indices based on 4948 reflections with I > 2s(I)
(refinement on F2), 258 parameters, 0 restraints. Lp and
absorption corrections applied, m = 3.532 mmꢁ1
.
Crystal data for 3. C21H22CdI2N6S2, M = 792.80, 0.180 ꢂ
ꢀ
Synthesis of {[CdLI2]ꢀ2CH3OH}n (4). 10.1 mg L (0.029 mmol)
was dissolved in 3 mL of MeOH and added to 21.2 mg
(0.058 mmol) CdI2 dissolved in 2 mL MeOH. The solvent
was allowed to evaporate slowly and after a period of 3 weeks
colourless crystals formed, and the structure was elucidated by
single-crystal X-ray diffraction.
0.120 ꢂ 0.080 mm, triclinic, space group P1 (No. 2), a =
9.6481(9), b = 11.2186(10), c = 14.1622(13) A, a =
112.0230(10), b = 91.681(2), g = 101.926(2)1, V = 1380.7(2) A3,
Z = 2, Dc = 1.907 g cmꢁ3, F000 = 760, Mo-Ka radiation,
l = 0.71073 A, T = 100(2) K, 2ymax = 56.61, 16003 reflections
collected, 6381 unique (Rint = 0.0425). Final GooF = 1.080,
c
2456 New J. Chem., 2010, 34, 2451–2457 This journal is The Royal Society of Chemistry and the Centre National de la Recherche Scientifique 2010